Haematology & Oncology
Antimicrobial Prophylaxis in Haematology & Oncology Patients
|
Indication |
|
Prophylaxis against muco-cutaneous candida infection (not recommended if anticipated duration of neutropenia <7 days) |
|
First Line Antimicrobials |
|
Nystatin 4mL QDS - Patient needs to be able to swish suspension in mouth and then swallow OR Fluconazole # 50mg OD PO # Consider potential for interactions with other drugs including those that may prolong the QT interval and drugs metabolised by CYP3A or P-gp. Please check SmPC or with pharmacy |
|
Indication |
|
Primary prophylaxis against aspergillus or mould infection, indicated for
For patients with prior history of invasive fungal infection (with aspergillus or other mould), always discuss antifungal prophylaxis choice with clinical microbiologist |
|
First Line Antimicrobials |
|
Posaconazole TABS # 300mg BD on day 1 300mg OD day 2 onwards #Consider potential for interactions with other drugs including those that may prolong the QT interval and drugs metabolised by CYP3A or P-gp. Please check SmPC or with pharmacy NB. POSACONAZOLE TABLET & LIQUID FORMS ARE NOT INTERCHANGEABLE – DOSES ARE DIFFERENT If posaconazole contra-indicated, discuss alternative agent with clinical microbiology team |
|
Indication |
|
Prophylaxis against reactivation of HSV, indicated for
|
|
First Line Antimicrobials |
|
Valaciclovir 500mg OD PO |
|
Indication |
|
Prophylaxis against Pneumocystis jirovecii pneumonia (PJP), indicated for
|
|
First Line Antimicrobials |
|
Co-trimoxazole 480mg OD PO If creatinine >250: Co-trimoxazole 480mg ALTERNATE DAYS PO If intolerant of or allergic to co-trimoxazole: Atovaquone 1500mg OD PO (take with food) |
|
Comments |
|
Co-trimoxazole (TMP-SMX) also provides prophylaxis against toxoplasmosis, nocardioisis, listeriosis, actinomycosis and infection with susceptible Enterobacterales |
Sickle Cell Disease Crisis
|
Indication |
|
Sickle Cell Disease Crisis with Evidence of Infection |
|
First Line Antimicrobials |
|
Cef-TRI-axone 2g OD IV ADD Clarithromycin 500mg BD PO ( or Clarithromycin 500mg BD IV only where oral route is not feasible - excellent oral bioavailability) if evidence of community-acquired pneumonia. |
|
Comments |
|
N.B. Send blood cultures, MSU, stool (if diarrhoea), sputum/ respiratory viral swab/ pneumocococcal and legionella urinary antigens (if respiratory infection). Consider malaria and refer to Malaria treatment guideline if relevant travel history. People with sickle cell disease (SCD) have an increased risk of severe bacterial infection, resulting primarily from asplenia or hyposplenia. On recovery from acute infection, they should start (or restart) antibiotic prophylaxis (usually penicillin) and receive relevant vaccinations. Please refer to splenic dysfunction prophylaxis guideline for detailed guidance on prevention of infection in this patient population. |
|
Duration of treatment |
|
Review at 48 hours with culture results. |
